Skip to main content
. 2010 Jul;70(1):34–42. doi: 10.1111/j.1365-2125.2010.03652.x

Figure 3.

Figure 3

Mean plasma concentration–time profiles for A) glucose, B) insulin and C) glucagon after 28 days of morning (n = 38) or evening (n = 38) administration of vildagliptin 100 mg, and during the placebo run-in (n = 45). Data are mean ± SEM. Run-in (Inline graphic); Morning dose (Inline graphic); Evening dose (Inline graphic)